Peer Review History
| Original SubmissionFebruary 11, 2020 |
|---|
|
Dear Dr. Maree, Thank you very much for submitting your manuscript "Symmetrical arrangement of positively charged residues around the 5-fold axes of SAT type foot-and-mouth disease virus enhances cell culture of field viruses" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments. Each of the reviewers makes specific comments that should be addressed in a revised version of the manuscript. In particular, we would like you to address the novelty of this work and its suitability for PLoS Pathogens. We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation. When you are ready to resubmit, please upload the following: [1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. [2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file). Important additional instructions are given below your reviewer comments. Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts. Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, Richard J. Kuhn, PhD Associate Editor PLOS Pathogens Michael Diamond Section Editor PLOS Pathogens Kasturi Haldar Editor-in-Chief PLOS Pathogens orcid.org/0000-0001-5065-158X Michael Malim Editor-in-Chief PLOS Pathogens *********************** Each of the reviewers makes specific comments that should be addressed in the revised version of the manuscript. In particular I would like you to address the novelty of this work and its suitability for PLoS Pathogens. Reviewer's Responses to Questions Part I - Summary Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship. Reviewer #1: FMDVs remain as significant threats to poultry and livestock industry. Developing vaccines from emerging new strains are difficult due to that some of the field viruses are unable to be adapted to cell cultures. This study analyzed the mutations of cell-culture-adapted field viruses. Many of these mutations are positively charged residues clustered around the icosahedral five-fold axis. The authors then designed a series of experiments to show that these mutated viruses have adapted new host receptors, heparin sulfate proteoglycan (HSPG). They also generated chimera viruses that mimic those observed mutations. These chimera viruses were able to adapt to cell culture well, which provide a novel way to quickly adapt emerging field viruses to cell culture for vaccine developments. The molecular virology experiments are thoroughly designed, and the results are rich and convincing. Many different aspects have been tested and discussed. This part is the strength of the paper. The molecular simulation docking is OK but not as convincing as the other experiments. With highly positively charged 5-fold, the negatively charged heparin will be docked there. The most convincing results will be a structure of the virus/heparin complex. With current cryo-EM techniques, obtain a complex structure using purified virus and heparin can be done very quickly. No need to obtain atomic resolution. Extra densities on the five-fold positively charged areas will prove the virus has adapted heparin as the receptor if using purified virus incubate with heparin. The author team has an expert in using cryo-EM to solve picornavirus structures. In summary, the paper is a very good one with a lot of convincing data from lab experiments. The simulation part is not necessary. Completely remove the simulation will not affect the significance of the discovery. Normally simulation can provide useful hints or suggestions for designing lab experiments. Here, the reviewer does not see that. Simulation itself cannot be a strong data to prove the receptor binding. Reviewer #2: Symmetrical arrangement of positively charged residues around the 5-fold axes of SAT type foot-and-mouth disease virus enhances cell culture of field viruses. FMD viruses of Southern African Territories (SAT) serotypes were adapted to growth on the BHK cell line. Adapted viruses gained the ability to enter cells by interaction with heparan sulphate proteoglycan (HSPG) via the selection of synonymous substitutions resulting in increased positive charge around the 5-fold symmetry axis of the viral capsid. The most important residues for adaptation were confirmed by characterising modified viruses generated by reverse genetics. This is a meticulous study by well-respected authors which has generated robust data which adds some new information to the process of culture adaptation of FMDV. Reviewer #3: The submitting groups here have a long background in FMDV and the manuscript is correspondingly authoritative. In the main the data hangs together well. The subject is the more problematic members of the FMDV serotypes, SAT1 and SAT2, generally regarded as difficult to grow and/or unstable. Selection of rapidly growing varants from the quasispecies by extensive passage results in isolates that bypass the integrin receptors and enter cells by the more generic mechanism of HS binding, as has been published for other serotypes. These viruses are characterized and reveal a predominance of charge changes with a subset of these clustered around the 5 fold axis. It is assumed the avidity of the cluster accounts for the new binding properties and to an extent this is confirmed by substitutions in molecular clones which indicate one (at 111-112 in VP1), sometimes with other surface exposed changes, are the key charged required. The knock-on of this is that field isolates required to be grown for vaccine use could be “fixed” by the introduction of the key change before being scaled up. This is useful but I did get the sense the story had been decided before the data were put together and a few more caveats might be wise. For example: I lost the connection, if there is one, with the mutation and plaque morphology. While size and opacity relate to virus yield they are also affected by cpe and cell to cell transmission. There is still quite a range of titres in the adapted viruses. Are we sure it's all just better entry=better yield? I think the exceptions illustrated by 158K and 83K in VP1 and 158K in VP3 need a little more weight. They are inhibited by heparin but do not go in BHKs. There is a trend in the manuscript to the view that +ve charge=HS binding=enhanced entry=enhanced yield. But these mutants do not fit - why not? What’s not right about them? I think the application should be more reserved. Only two of the final mutants reach titres (>10^8) that would be respectable enough for mass culture and it remains to be seen how many field isolates would do the same when engineered in this way. It seems probable that the mutants here would generate the same antibody response on immunisation at the WT but it is not yet proven. It's possible that they could affect antigen processing. There are recombinant routes to FMDV vaccines, the rec.Adeno for example, where the need to culture is bypassed anyway. Would these mutations benefit or hinder such approaches? ********** Part II – Major Issues: Key Experiments Required for Acceptance Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions. Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject". Reviewer #1: No major issues have been found. However, the reviewer suggests the authors to add discussions about whether making those chimeric viruses with positive charged residues clustered on the 5-fold vertices might alter the antigen properties of the viruses. The animal might develop immune response to those areas which might defeat the purposes of vaccine development of emerging field strains. Reviewer #2: This is a meticulous study by well-respected authors which has generated robust data which adds some new information to the process of culture adaptation of FMDV. However, the main claims of the study are already very well established. References (cited in the manuscript) 21, 44, 45 and 23, all describe previous culture adaptation of FMDV involving acquisition of positive charge around the five-fold axis. Therefore, the novelty of the current study is not what would normally be consistent with publication in PLoS Pathogens. What is of more concern is that the introduction and discussion does not make this situation clear. Despite the references being cited within the paper, there is no explanation in the introduction, of these previous studies (e.g. references 21, 44, 45, 23) having already identified acquisition of positive charge around the 5-fold as a mechanism of culture adaptation. This seems bizarre. Instead the following statement is included: “The genetic alterations associated with increased cell killing activity during cytolytic passages of the SAT serotype FMD viruses in BHK-21 cells are largely unknown. Nevertheless, it has been noted that amino acid substitutions accumulate in their capsids during serial passaging (44–46)” One of the references at the end of this statement is even from one of the authors of the current study and specifically describes the acquisition of positive charge around the five-fold as a mechanism of culture adaptation of SAT type viruses. In the context of the novel claims of the current manuscript this statement and other omissions appear misleading. Perhaps hopefully all of this is the result of lack of oversight, but I’m afraid it is rather disappointing. Reviewer #3: None ********** Part III – Minor Issues: Editorial and Data Presentation Modifications Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. Reviewer #1: 1. The paper still contains some typos that need to be read carefully and correct. Eg. In Ln177 “the roadmap programme”, the Roadmap should be capitalized to be consistent with Ln534. Another example in Ln263 “heparinise” should be “heparinase”? 2. The authors need to check all the references carefully. Some of the references are not correctly cited. For example, for the same Ln177 mentioned above. Reference 48 is not the Roadmap program but the program GRID for docking as shown in Ln191. Again, on Ln534, the Roadmap was cited as reference 47, which is a very old review paper for virus-polysaccharide interactions. None of the Roadmap was cited properly. The reviewer does not have time to check all the references for the authors. 3. In order to improve the readability, instead of writing the mutagenesis primer sequences in the text (Ln455 to 463), the reviewer suggests the authors to list them in a table. Reviewer #2: It was not clear what significance is provided by the in-silico docking analysis. Also it is only referred to as GRID, a non-expert introduction to what this means and how it works would be useful. I found the description and nomenclature of the engineered viruses was difficult to follow. Reviewer #3: See above ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No Figure Files: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Data Requirements: Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here on PLOS Biology: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5. Reproducibility: To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plospathogens/s/submission-guidelines#loc-materials-and-methods |
| Revision 1 |
|
Dear Dr. Maree, Thank you very much for submitting your manuscript "Symmetrical arrangement of positively charged residues around the 5-fold axes of SAT type foot-and-mouth disease virus enhances cell culture of field viruses" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations. The authors have responded appropriately to most comments by the reviewers. However, Reviewer #2 had some specific questions regarding the novelty of the work but more specifically the way the authors referred to prior work and discussed this in the context of this manuscript; The comments in questions are: Reviewer #2: This is a meticulous study by well-respected authors which has generated robust data which adds some new information to the process of culture adaptation of FMDV. However, the main claims of the study are already very well established. References (cited in the manuscript) 21, 44, 45 and 23, all describe previous culture adaptation of FMDV involving acquisition of positive charge around the five-fold axis. Therefore, the novelty of the current study is not what would normally be consistent with publication in PLoS Pathogens. What is of more concern is that the introduction and discussion does not make this situation clear. Despite the references being cited within the paper, there is no explanation in the introduction, of these previous studies (e.g. references 21, 44, 45, 23) having already identified acquisition of positive charge around the 5-fold as a mechanism of culture adaptation. This seems bizarre. Instead the following statement is included: “The genetic alterations associated with increased cell killing activity during cytolytic passages of the SAT serotype FMD viruses in BHK-21 cells are largely unknown. Nevertheless, it has been noted that amino acid substitutions accumulate in their capsids during serial passaging (44–46)” One of the references at the end of this statement is even from one of the authors of the current study and specifically describes the acquisition of positive charge around the five-fold as a mechanism of culture adaptation of SAT type viruses. In the context of the novel claims of the current manuscript this statement and other omissions appear misleading. Perhaps hopefully all of this is the result of lack of oversight, but I’m afraid it is rather disappointing. The authors have removed the statement that is mentioned but they have not addressed the central concern of the reviewer. They need to be clear on the response about these concerns. Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. When you are ready to resubmit, please upload the following: [1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out [2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file). Important additional instructions are given below your reviewer comments. Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, Richard J. Kuhn, PhD Associate Editor PLOS Pathogens Michael Diamond Section Editor PLOS Pathogens Kasturi Haldar Editor-in-Chief PLOS Pathogens orcid.org/0000-0001-5065-158X Michael Malim Editor-in-Chief PLOS Pathogens *********************** The authors have responded appropriately to most comments by the reviewers. However, Reviewer #2 had some specific questions regarding the novelty of the work but more specifically the way the authors referred to prior work and discussed this in the context of this manuscript; The comments in questions are: Reviewer #2: This is a meticulous study by well-respected authors which has generated robust data which adds some new information to the process of culture adaptation of FMDV. However, the main claims of the study are already very well established. References (cited in the manuscript) 21, 44, 45 and 23, all describe previous culture adaptation of FMDV involving acquisition of positive charge around the five-fold axis. Therefore, the novelty of the current study is not what would normally be consistent with publication in PLoS Pathogens. What is of more concern is that the introduction and discussion does not make this situation clear. Despite the references being cited within the paper, there is no explanation in the introduction, of these previous studies (e.g. references 21, 44, 45, 23) having already identified acquisition of positive charge around the 5-fold as a mechanism of culture adaptation. This seems bizarre. Instead the following statement is included: “The genetic alterations associated with increased cell killing activity during cytolytic passages of the SAT serotype FMD viruses in BHK-21 cells are largely unknown. Nevertheless, it has been noted that amino acid substitutions accumulate in their capsids during serial passaging (44–46)” One of the references at the end of this statement is even from one of the authors of the current study and specifically describes the acquisition of positive charge around the five-fold as a mechanism of culture adaptation of SAT type viruses. In the context of the novel claims of the current manuscript this statement and other omissions appear misleading. Perhaps hopefully all of this is the result of lack of oversight, but I’m afraid it is rather disappointing. The authors have removed the statement that is mentioned but they have not addressed the central concern of the reviewer. They need to be clear on the response about these concerns. Reviewer Comments (if any, and for reference): Figure Files: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Data Requirements: Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5. Reproducibility: To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plospathogens/s/submission-guidelines#loc-materials-and-methods |
| Revision 2 |
|
Dear Dr. Maree, We are pleased to inform you that your manuscript 'Symmetrical arrangement of positively charged residues around the 5-fold axes of SAT type foot-and-mouth disease virus enhances cell culture of field viruses' has been provisionally accepted for publication in PLOS Pathogens. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens. Best regards, Richard J. Kuhn, PhD Associate Editor PLOS Pathogens Michael Diamond Section Editor PLOS Pathogens Kasturi Haldar Editor-in-Chief PLOS Pathogens orcid.org/0000-0001-5065-158X Michael Malim Editor-in-Chief PLOS Pathogens *********************************************************** The authors have addressed the remaining concerns with this revision. It now is an important contribution to the FMDV field. Reviewer Comments (if any, and for reference): |
| Formally Accepted |
|
Dear Dr. Maree, We are delighted to inform you that your manuscript, "Symmetrical arrangement of positively charged residues around the 5-fold axes of SAT type foot-and-mouth disease virus enhances cell culture of field viruses," has been formally accepted for publication in PLOS Pathogens. We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly. Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens. Best regards, Kasturi Haldar Editor-in-Chief PLOS Pathogens orcid.org/0000-0001-5065-158X Michael Malim Editor-in-Chief PLOS Pathogens |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .